Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 67, Suppl. 1, 2007   

Free Abstract     Article (Fulltext)     Article (PDF 103 KB)     

Growth Hormone and Growth Factors in Endocrinology and Metabolism.
Editor(s): Koppeschaar, H.P.F. (Utrecht), Tuvemo, T. (Uppsala), Trainer, P. (Manchester), Zeitler, P. (Denver, Colo.)


Pediatric Clinical Case Sessions

Hepatic Enzyme Abnormalities in Turner Syndrome: A Case Report
P. Pervanidou, P. Xekouki, C. Dacou-Voutetakis

First Department of Pediatrics, Division of Endocrinology, Metabolism and Diabetes, University of Athens, 'Aghia Sophia' Children's Hospital, Athens, Greece

Address of Corresponding Author

Horm Res 2007;67 (Suppl. 1):106-108 (DOI: 10.1159/000097563)


 goto top of page Key Words

  • Turner syndrome
  • Hepatic enzymes
  • Hormone replacement therapy
  • Growth hormone
  • Liver

 goto top of page Abstract

Background: Liver dysfunction has been described in subjects with Turner syndrome. The mechanism involved is not known. Methods: Using appropriate methodology, we evaluated the hepatic enzymes serum glutamic-oxaloacetic transaminase, serum glutamic pyruvic transaminase and gamma-glutamyl transpeptidase (gamma-GT) in a girl with 45 XO/46 Xr mosaic karyotype. She was monitored from age 9 to 20 years while she underwent various therapeutic regimens. Results: Serum glutamic-oxaloacetic transaminase, serum glutamic pyruvic transaminase and particularly gamma-GT concentrations ranged from normal to elevated values during human growth hormone therapy, estrogen replacement therapy (conjugated estrogens were replaced after 1 year with transdermal estrogens and medroxyprogesterone), and periods without therapy. The type of the therapeutic regimen did not seem to influence the hepatic enzyme values. A correlation was found between gamma-GT values and body mass index (BMI). Conclusions: In our patient the waxing and waning of the liver enzymes was not influenced by the therapeutic regimen, but gamma-GT seemed to correlate with BMI.

Copyright © 2007 S. Karger AG, Basel


 goto top of page Author Contacts

Panagiota Pervanidou, MD
University of Athens, 'Aghia Sophia' Children's Hospital
First Department of Pediatrics, Division of Endocrinology, Metabolism and Diabetes
26 Charavgis Str., Athens, Chalandri 152 32 (Greece)
Tel. +30 210 683 3936, Fax +30 210 652 5013, E-Mail ppervanid@med.uoa.gr


 goto top of page Article Information

Published online: February 15, 2007
Number of Print Pages : 3
Number of Figures : 2, Number of Tables : 0, Number of References : 13

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 17308410)
Download Citation



This journal is part of the third subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.




copyright  © 2009 S. Karger AG, Basel